About this trial
The goal of this clinical trial is to learn if a dietary supplement called Miricell works to improve cellular health and signs of healthy aging in adults. It will also learn about the safety of Miricell.
The main questions it aims to answer are:
* Does Miricell improve markers of autophagy, which is the body's natural process for recycling damaged cells? * Does Miricell support brain health, metabolic health, and visible signs of aging? * What medical problems, if any, do participants experience while taking Miricell?
Researchers will compare Miricell to a placebo (a look-alike capsule that contains no active ingredients) to see if Miricell works better to support healthy aging.
Participants will:
* Take either one Miricell capsule or a placebo every day for 12 weeks with a morning meal. * Visit the research clinic four times over the course of the study for checkups and tests. * Complete memory and thinking tests, track their daily physical activity, and give blood samples to measure health changes.
Eligibility criteria
Qualifiers
Provide voluntary signed and dated informed consent.
Be in fair health as determined by medical history and routine blood chemistries.
Age between the ages of 40 and 70 (inclusive).
Body weight of at least 110 pounds.
Disqualifiers
Use of probiotics, postbiotics or antibiotics within the past month.
A history of unstable or new-onset cardiovascular/cardiorespiratory, liver, or renal disease.
The participant's alcohol consumption is more than two standard alcoholic drinks per day or more than 10 drinks per week or has a history of drug/alcohol abuse or dependence.
History of diabetes (any form) or any endocrine disorder.
Trial design
Treatments tested in this trial
- Spermidine
- Placebo
Treatment groups
Sponsors and collaborators
Nutraland USA, Inc.
Lead sponsor
The Center for Applied Health Sciences, LLC
Collaborator